Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,106 | 1,372 | 50.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18,720 | 12 | 44.6% |
| Travel and Lodging | $1,890 | 13 | 4.5% |
| Education | $233.77 | 15 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $22,537 | 107 | $0 (2022) |
| ABBVIE INC. | $2,177 | 146 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,096 | 89 | $0 (2024) |
| Novo Nordisk Inc | $1,781 | 149 | $0 (2024) |
| PFIZER INC. | $1,334 | 124 | $0 (2024) |
| Amgen Inc. | $1,290 | 62 | $0 (2024) |
| Lilly USA, LLC | $700.13 | 52 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $661.67 | 49 | $0 (2023) |
| Merck Sharp & Dohme LLC | $605.16 | 38 | $0 (2024) |
| GlaxoSmithKline, LLC. | $587.37 | 49 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,723 | 171 | ABBVIE INC. ($403.38) |
| 2023 | $3,118 | 165 | AbbVie Inc. ($452.43) |
| 2022 | $3,672 | 193 | ABBVIE INC. ($611.88) |
| 2021 | $2,712 | 163 | AbbVie Inc. ($661.84) |
| 2020 | $1,772 | 127 | Novo Nordisk Inc ($222.98) |
| 2019 | $2,501 | 213 | AstraZeneca Pharmaceuticals LP ($381.81) |
| 2018 | $5,912 | 175 | Janssen Pharmaceuticals, Inc ($4,097) |
| 2017 | $19,539 | 205 | Janssen Pharmaceuticals, Inc ($17,664) |
All Payment Transactions
1,412 individual payment records from CMS Open Payments — Page 1 of 57
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: RESPIRATORY | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Gastroenterology | ||||||
| 12/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: PAIN | ||||||
| 12/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $9.81 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.64 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Neurology | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $30.69 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $1.25 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.99 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | PROTEGA PHARMACEUTIALS INC | ROXYBOND (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Pain Management | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Gastroenterology | ||||||
| 11/12/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Endocrinology | ||||||
| 11/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Diabetes Care | ||||||
| 11/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: PAIN | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $2.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.03 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.22 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Respiratory | ||||||
| 11/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $2.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 703 | 969 | $116,642 | $62,091 |
| 2022 | 8 | 711 | 1,037 | $124,391 | $62,266 |
| 2021 | 8 | 644 | 1,016 | $104,751 | $58,720 |
| 2020 | 14 | 966 | 1,387 | $138,207 | $65,630 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 238 | 301 | $42,742 | $21,307 | 49.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 201 | 295 | $35,400 | $16,141 | 45.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 100 | 100 | $16,500 | $12,058 | 73.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 24 | 24 | $5,136 | $3,719 | 72.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 14 | 14 | $4,858 | $2,870 | 59.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $2,832 | $1,825 | 64.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 12 | 12 | $2,940 | $1,815 | 61.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 78 | 78 | $2,106 | $1,310 | 62.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 20 | 129 | $4,128 | $1,047 | 25.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 280 | 351 | $49,842 | $24,515 | 49.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 246 | 382 | $45,840 | $20,371 | 44.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 108 | 108 | $17,820 | $13,197 | 74.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $3,717 | $1,760 | 47.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 17 | 135 | $4,320 | $1,227 | 28.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $1,705 | $833.90 | 48.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 16 | 16 | $432.00 | $266.72 | 61.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 13 | $715.00 | $95.12 | 13.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 304 | 536 | $48,960 | $29,296 | 59.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 172 | 194 | $27,548 | $12,956 | 47.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 98 | 98 | $16,170 | $12,222 | 75.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 19 | 65 | $4,745 | $1,818 | 38.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 12 | 12 | $2,124 | $921.45 | 43.4% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 15 | 87 | $2,784 | $740.72 | 26.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 11 | 11 | $1,705 | $644.75 | 37.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 13 | 13 | $715.00 | $121.00 | 16.9% |
About Dr. Damon Travis, D.O
Dr. Damon Travis, D.O is a Family Medicine healthcare provider based in Harrisonville, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578583852.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Damon Travis, D.O has received a total of $41,950 in payments from pharmaceutical and medical device companies, with $2,723 received in 2024. These payments were reported across 1,412 transactions from 77 companies. The most common payment nature is "Food and Beverage" ($21,106).
As a Medicare-enrolled provider, Travis has provided services to 3,024 Medicare beneficiaries, totaling 4,409 services with total Medicare billing of $248,707. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Harrisonville, MO
- Active Since 07/20/2006
- Last Updated 01/13/2026
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1578583852
Products in Payments
- INVOKANA (Drug) $21,653
- VRAYLAR (Drug) $1,248
- FARXIGA (Drug) $924.59
- XARELTO (Drug) $877.42
- Ozempic (Drug) $682.51
- NURTEC ODT (Drug) $586.30
- REXULTI (Drug) $506.35
- UBRELVY (Drug) $481.51
- BREZTRI (Drug) $463.26
- CAPLYTA (Drug) $460.37
- ELIQUIS (Drug) $428.12
- Otezla (Drug) $421.49
- Repatha (Biological) $407.32
- CHANTIX (Drug) $358.69
- Kerendia (Drug) $357.35
- JARDIANCE (Drug) $339.35
- FREESTYLE LIBRE 3 (Device) $313.02
- QULIPTA (Drug) $312.57
- Victoza (Drug) $302.60
- Dexcom G6 Transmitter (Medical Supply) $296.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Harrisonville
Dr. Srinath Tadakamalla, M.d, M.D
Family Medicine — Payments: $64,063
Richard Price, M.d, M.D
Family Medicine — Payments: $9,864
Heather Bloesser, Do, DO
Family Medicine — Payments: $6,376
Samuel Brewster, M.d, M.D
Family Medicine — Payments: $4,658
Shaun Holden, M.d, M.D
Family Medicine — Payments: $4,224
Dr. Cassandra Brewster, Md, MD
Family Medicine — Payments: $2,590